Cargando…

Ketamine and Lamotrigine Combination in Psychopharmacology: Systematic Review

Background and Objectives: Ketamine is a rapid-acting antidepressant with proven efficacy as an add-on agent in unipolar and bipolar treatment-resistant depression. Although many studies have been published, there is still not enough data on the effect of ketamine in combination with other medicatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Wilkowska, Alina, Wiglusz, Mariusz S., Jakuszkowiak-Wojten, Katarzyna, Cubała, Wiesław J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8869907/
https://www.ncbi.nlm.nih.gov/pubmed/35203296
http://dx.doi.org/10.3390/cells11040645
_version_ 1784656607353765888
author Wilkowska, Alina
Wiglusz, Mariusz S.
Jakuszkowiak-Wojten, Katarzyna
Cubała, Wiesław J.
author_facet Wilkowska, Alina
Wiglusz, Mariusz S.
Jakuszkowiak-Wojten, Katarzyna
Cubała, Wiesław J.
author_sort Wilkowska, Alina
collection PubMed
description Background and Objectives: Ketamine is a rapid-acting antidepressant with proven efficacy as an add-on agent in unipolar and bipolar treatment-resistant depression. Although many studies have been published, there is still not enough data on the effect of ketamine in combination with other medications. Particularly interesting is the combination of ketamine and lamotrigine, and its potential role in bipolar depression. The aim of this review was to identify animal and human studies in which ketamine and lamotrigine were used together in order to find out if there is scientific ground for combining ketamine and lamotrigine in the treatment of mood disorders. Directions for future studies are presented. Materials and Methods: PubMed and Web of Science were searched. Preferred Reporting Items for Systematic Reviews and Meta-Analyses PRISMA 2020 methodology was applied. Results: Seventeen studies were included for review. Animal studies using models of depression suggested a synergistic effect of ketamine and lamotrigine in combination. Studies on healthy humans showed a reduction in ketamine-induced dissociative symptoms with lamotrigine pretreatment. In a study on patients with depression, ketamine and lamotrigine did not have a stronger antidepressant effect than ketamine alone, but in this study only one ketamine infusion was administered. One case series described the antidepressant and anti-suicidal effect of the combination in two bipolar patients. Available clinical studies on patients with mood disorders did not support the hypothesis that lamotrigine reduces ketamine-induced dissociative symptoms. Conclusions: The results of the analyzed studies were not sufficient to answer any of the stated questions; however, they allowed us to delineate future research directions. The identified animal studies suggested a possible synergistic antidepressant effect of ketamine and lamotrigine. The available clinical studies were not conclusive. No controlled studies on large groups of bipolar patients with multiple ketamine infusions combined with lamotrigine treatment have been published so far. There is some evidence for the reduction of ketamine’s side effects by lamotrigine, and there are reports suggesting that lamotrigine can reduce ketamine craving. More studies with follow-up are needed in order to investigate the ketamine–lamotrigine combination in bipolar patients.
format Online
Article
Text
id pubmed-8869907
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-88699072022-02-25 Ketamine and Lamotrigine Combination in Psychopharmacology: Systematic Review Wilkowska, Alina Wiglusz, Mariusz S. Jakuszkowiak-Wojten, Katarzyna Cubała, Wiesław J. Cells Systematic Review Background and Objectives: Ketamine is a rapid-acting antidepressant with proven efficacy as an add-on agent in unipolar and bipolar treatment-resistant depression. Although many studies have been published, there is still not enough data on the effect of ketamine in combination with other medications. Particularly interesting is the combination of ketamine and lamotrigine, and its potential role in bipolar depression. The aim of this review was to identify animal and human studies in which ketamine and lamotrigine were used together in order to find out if there is scientific ground for combining ketamine and lamotrigine in the treatment of mood disorders. Directions for future studies are presented. Materials and Methods: PubMed and Web of Science were searched. Preferred Reporting Items for Systematic Reviews and Meta-Analyses PRISMA 2020 methodology was applied. Results: Seventeen studies were included for review. Animal studies using models of depression suggested a synergistic effect of ketamine and lamotrigine in combination. Studies on healthy humans showed a reduction in ketamine-induced dissociative symptoms with lamotrigine pretreatment. In a study on patients with depression, ketamine and lamotrigine did not have a stronger antidepressant effect than ketamine alone, but in this study only one ketamine infusion was administered. One case series described the antidepressant and anti-suicidal effect of the combination in two bipolar patients. Available clinical studies on patients with mood disorders did not support the hypothesis that lamotrigine reduces ketamine-induced dissociative symptoms. Conclusions: The results of the analyzed studies were not sufficient to answer any of the stated questions; however, they allowed us to delineate future research directions. The identified animal studies suggested a possible synergistic antidepressant effect of ketamine and lamotrigine. The available clinical studies were not conclusive. No controlled studies on large groups of bipolar patients with multiple ketamine infusions combined with lamotrigine treatment have been published so far. There is some evidence for the reduction of ketamine’s side effects by lamotrigine, and there are reports suggesting that lamotrigine can reduce ketamine craving. More studies with follow-up are needed in order to investigate the ketamine–lamotrigine combination in bipolar patients. MDPI 2022-02-12 /pmc/articles/PMC8869907/ /pubmed/35203296 http://dx.doi.org/10.3390/cells11040645 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Systematic Review
Wilkowska, Alina
Wiglusz, Mariusz S.
Jakuszkowiak-Wojten, Katarzyna
Cubała, Wiesław J.
Ketamine and Lamotrigine Combination in Psychopharmacology: Systematic Review
title Ketamine and Lamotrigine Combination in Psychopharmacology: Systematic Review
title_full Ketamine and Lamotrigine Combination in Psychopharmacology: Systematic Review
title_fullStr Ketamine and Lamotrigine Combination in Psychopharmacology: Systematic Review
title_full_unstemmed Ketamine and Lamotrigine Combination in Psychopharmacology: Systematic Review
title_short Ketamine and Lamotrigine Combination in Psychopharmacology: Systematic Review
title_sort ketamine and lamotrigine combination in psychopharmacology: systematic review
topic Systematic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8869907/
https://www.ncbi.nlm.nih.gov/pubmed/35203296
http://dx.doi.org/10.3390/cells11040645
work_keys_str_mv AT wilkowskaalina ketamineandlamotriginecombinationinpsychopharmacologysystematicreview
AT wigluszmariuszs ketamineandlamotriginecombinationinpsychopharmacologysystematicreview
AT jakuszkowiakwojtenkatarzyna ketamineandlamotriginecombinationinpsychopharmacologysystematicreview
AT cubaławiesławj ketamineandlamotriginecombinationinpsychopharmacologysystematicreview